Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Curative [cnce]    
resect [topp]    
Hepatocellular carcinoma [neop]    
Non [ftcn]    
RANDOM [resa]    
Comparative Studies [inpr]    
Background [cnce]    
Aim [idcn]    
PREVENT [topp]    
Recurrence [phpr]    
Most [qnco]    
strategies [menp]    
Long-term [tmco]    
Survival [acty]    
resect [topp]    
Hepatocellular carcinoma [neop]    
This [euka]    
Comparative Studies [inpr]    
Aim [idcn]    
To [qlco]    
Evaluable [ftcn]    
Outcome [ftcn]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Hepatectomies [topp]    
methodology [inpr]    
Consecutive [qlco]    
patient [podg]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
treatment [ftcn]    
Control Group [grup]    
resect [topp]    
Hepatocellular carcinoma [neop]    
Analyzed [resa]    
prospective [resa]    
Data [idcn]    
Analyzed [resa]    
Result [ftcn]    
median [spco]    
Follow-up [fndg]    
month [tmco]    
patient [podg]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
patient [podg]    
Control Group [grup]    
Recurrent disease [dsyn]    
Significance [qnco]    
*Difference [qnco]    
recurrence tumor [neop]    
Rate [acty]    
+2 [qnco]    
Group [idcn]    
Significance [qnco]    
*Difference [qnco]    
recurrence tumor [neop]    
Time [tmco]    
+2 [qnco]    
Group [idcn]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
overall survival rate [qnco]    
55 [inpr]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
Control Group [grup]    
1+ [qnco]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Disease-Free Survival [qnco]    
Rate [acty]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
31 [inpr]    
Control Group [grup]    
*Difference [qnco]    
Disease-Free Survival [qnco]    
Rate [acty]    
overall survival rate [qnco]    
+2 [qnco]    
Group [idcn]    
Significance [qnco]    
subgroup [virs]    
Analysis [lbpr]    
Significance [qnco]    
Survival [acty]    
Benefit [qnco]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
subgroup [virs]    
patient [podg]    
Risk factor [qnco]    
recurrence tumor [neop]    
Large [qnco]    
size [spco]    
Presence [topp]    
satellite tumor [patf]    
Nodule [acab]    
Narrow [qlco]    
resect [topp]    
Margin [spco]    
Conclusion [idcn]    
Adjuvant [chvf]    
Transarterial Chemoembolization [topp]    
Improved [qlco]    
Surgical [hlca]    
Outcome [ftcn]    
patient [podg]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
Recurrence [phpr]    
